Taiyo Nippon Sanso $5.9 billion acquisition of Praxair assets

5/7/2018

Asset acquisition

Value:

$ 5.9 billion

Status:

Announced

Date:

5/7/2018

Overview:

The deal is a latest string in a series of acquisitions including Takeda Pharmaceutical £46 billion acquisition of Shire, part of a global Japanese overseas assets expansion trend.
Praxair's divestment is connected with its $83 billion merger with Linde.

Daniel Semerdzhiev - Data analyst

Jurisdictions:

Japan
Germany

Deal type:

Asset acquisition

Practice area:

M&A

Governing law:

Germany

Industry sector:

Oil and gas

Firms:

Greenberg Traurig

Party: Taiyo Nippon Sanso (Acquirer)

Lawyers: Brian Petrequin, Eva Herdé, Henrik Armah, Kati Beckmann, Koji Ishikawa, Lee Albanese, Paul Maher, Peter Schorling, Philipp Osteroth, Sarah Moyles

McDermott Will & Emery

Party: Praxair (Seller)

Lawyers: Elisabeth Moseley, Joanna Jung-Erh Lin, Marta Wrobel, Matthew Chen, Shawn Helms

Related deals